1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Guangzhou Kingmed Diagnostics Group Co., Ltd.
  6. News
  7. Summary
    603882   CNE100002VW1

GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.

(603882)
  Report
End-of-day quote Shanghai Stock Exchange  -  05-16
82.50 CNY   -1.23%
04/29UBS Adjusts Guangzhou Kingmed Diagnostics' Price Target to 97 Yuan From 100 Yuan, Keeps at Buy
MT
04/26Guangzhou Kingmed Diagnostics Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
04/20UBS Adjusts Guangzhou Kingmed Diagnostics' Price Target to 100 Yuan From 230 Yuan, Keeps at Buy
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

China's Tianjin outbreak grows as Omicron spreads to Dalian

01/12/2022 | 09:57pm EDT

BEIJING, Jan 13 (Reuters) - China's northern port city of Tianjin reported an increase in COVID-19 infections on Thursday as it stepped up efforts to rein in an outbreak that has spread the highly transmissible Omicron variant to another city.

Omicron has brought new challenges for China's strategy to quickly stamp out outbreaks, which has taken on urgency ahead of the Winter Olympics set to start from Feb. 4, while the busy Lunar New Year travel season begins this month.

Volkswagen Group's China unit said it had shut a vehicle plant run jointly with FAW Group in Tianjin, as well as a component factory since Monday due to the outbreak.

Tianjin, located about 100 km (62 miles) from the capital Beijing, reported 41 domestically transmitted infections with confirmed symptoms on Wednesday, up from 33 a day earlier, National Health Commission data showed.

Dalian in the northeast also reported an individual arriving from Tianjin had tested positive for Omicron, city officials said. It said the virus situation was "largely controllable".

Anyang in the central province of Henan reported 43 local symptomatic cases on Wednesday, after two Omicron infections on Monday. It traced the flare-up to a student from Tianjin.

Case numbers in Tianjin and Anyang are tiny compared with outbreaks in many other countries, though the number of local Omicron infections is unclear. Still, officials imposed curbs on movement within the cities and outside.

Several cities across China have ordered quarantine for recent visitors to the two cities. Beijing is among the many cities urging people to stay put during the Lunar New Year holiday.

Citing the Omicron risk and the need to keep the Olympics Games safe, officials in the capital encouraged commuters from satellite towns to work from home.

There were no new deaths on Wednesday, leaving the toll since the virus was first found two years ago in China unchanged at 4,636.

IMPORTED INFECTIONS

Zhang Wenhong, director of a COVID-19 treatment team in Shanghai, said on Thursday the public health clinic in the commercial hub faced a record number of infections arriving from overseas.

Imported cases in Shanghai during the first 10 days of this month have already exceeded December's total, Reuters calculations showed. How many were caused by Omicron is unclear.

China has suspended more U.S. flights after a surge in numbers of infected passengers.

Its tough measures against local outbreaks included punishment for officials, with 11 people held to account in Anyang by Wednesday for failing to properly control the virus.

On Thursday, city authorities in the ancient town of Xian ordered two hospitals to suspend operations for three months for failures in providing medical care during the outbreak.

The move drove down shares of their owner, XiAn International Medical Investment Co, by 10%, or the maximum permitted daily percentage change.

One of the hospitals apologised for rigid virus controls that delayed treatment for a patient who suffered a heart attack and died.

The story of a pregnant woman who lost her unborn baby after waiting for two hours outside the other hospital provoked anger on Chinese social media and brought punishment for city officials. (Reporting by Roxanne Liu, Ella Cao and David Stanway; Editing by Tom Hogue and Clarence Fernandez)


ę Reuters 2022
Stocks mentioned in the article
ChangeLast1st jan.
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD. -1.23% 82.5 End-of-day quote.-25.92%
ON SEMICONDUCTOR CORPORATION 6.07% 58.5 Delayed Quote.-13.87%
VOLKSWAGEN AG 1.04% 147.44 Delayed Quote.-17.78%
XI'AN INTERNATIONAL MEDICAL INVESTMENT COMPANY LIMITED 2.00% 8.66 End-of-day quote.-21.49%
All news about GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.
04/29UBS Adjusts Guangzhou Kingmed Diagnostics' Price Target to 97 Yuan From 100 Yuan, Keeps..
MT
04/26Guangzhou Kingmed Diagnostics Group Co., Ltd. Reports Earnings Results for the First Qu..
CI
04/20UBS Adjusts Guangzhou Kingmed Diagnostics' Price Target to 100 Yuan From 230 Yuan, Keep..
MT
01/12China's Tianjin outbreak grows as Omicron spreads to Dalian
RE
2021Guangzhou Kingmed Diagnostics Group Co., Ltd. Reports Earnings Results for the Nine Mon..
CI
2021Guangzhou Kingmed Diagnostics Group Co., Ltd. Reports Earnings Results for the Half Yea..
CI
2021China stocks slip as healthcare firms retreat; Hong Kong up
RE
2021GUANGZHOU KINGMED DIAGNOSTICS GROUP : 603882) added to Shanghai Stock Exchange 180 Value ..
CI
2021Guangzhou Kingmed Diagnostics' Shareholder to Unload Up to 6% Stake
CI
2021Guangzhou Kingmed Diagnostics Group Co., Ltd. Reports Earnings Results for the First Qu..
CI
More news
Analyst Recommendations on GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.
More recommendations
Financials
Sales 2022 14 464 M 2 147 M 2 147 M
Net income 2022 2 566 M 381 M 381 M
Net cash 2022 3 928 M 583 M 583 M
P/E ratio 2022 14,8x
Yield 2022 1,07%
Capitalization 38 428 M 5 703 M 5 703 M
EV / Sales 2022 2,39x
EV / Sales 2023 2,38x
Nbr of Employees 12 371
Free-Float 54,4%
Chart GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.
Duration : Period :
Guangzhou Kingmed Diagnostics Group Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 9
Last Close Price 82,50 CNY
Average target price 123,98 CNY
Spread / Average Target 50,3%
EPS Revisions
Managers and Directors
Yao Ming Liang Chairman & General Manager
Bi Xi Hao CFO, Secretary, Director & Deputy General Manager
Yong Jian Chen Chairman-Supervisory Board
Shi Hui Yu Chief Scientist & Deputy General Manager
Jing Ming Xu Independent Director
Sector and Competitors